Literature DB >> 8611059

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.

R F Anton1, D H Moak, P K Latham.   

Abstract

BACKGROUND: the 14-item Obsessive Compulsive Drinking Scale (OCDS) is a quick and reliable self-rating instrument that provides a total and two subscale scores that measure some cognitive aspects of alcohol "craving". This study validated further its utility as an alcoholism severity and treatment outcome instrument.
METHODS: Alcoholism severity and analogue craving scales were administered at baseline, and the OCDS was given at baseline and weekly to 41 alcohol-dependent individuals who participated in a 12-week pharmacologic and cognitive-behavioral treatment trial. Repeated-measures analysis of variance was used to examine group differences in the OCDS scores of those individuals who remained abstinent or drank during the trial.
RESULTS: At baseline, the OCDS was correlated with the alcohol composite score of the addiction severity index (r=.48), the alcohol dependence scale (r=.42), the analogue craving measures (range r=.40 to .57), and prestudy alcohol consumption (r=.60). Most importantly the OCDS total and subscale scores were significantly different between individuals who had relapse drinking, who had "slip" drinking, and who remained abstinent, with relapsers showing the highest scores.
CONCLUSIONS: The OCDS scores appear to be sensitive to alcoholism severity and change during abstinence and relapse drinking. Since the shared variance with analogue craving measures is only about 20% to 30%, it appears to be measuring a largely independent dimension of alcohol dependence. Its ease of use (5 minutes per self-rating), reliability, validity, and analytic capabilities support its utility as a tool to measure severity and improvement during alcoholism treatment trials.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611059     DOI: 10.1001/archpsyc.1996.01830030047008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  120 in total

Review 1.  Human laboratory paradigms in alcohol research.

Authors:  Jennifer G Plebani; Lara A Ray; Meghan E Morean; William R Corbin; James MacKillop; Michael Amlung; Andrea C King
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

2.  Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Authors:  Shelly F Greenfield; Helen M Pettinati; Stephanie O'Malley; Patrick K Randall; Carrie L Randall
Journal:  Alcohol Clin Exp Res       Date:  2010-07-20       Impact factor: 3.455

3.  Relations Between Cognitive Functioning and Alcohol Use, Craving, and Post-Traumatic Stress: An Examination Among Trauma-Exposed Military Veterans With Alcohol Use Disorder.

Authors:  Adrienne J Heinz; David L Pennington; Nicole Cohen; Brandi Schmeling; Brooke A Lasher; Emily Schrodek; Steven L Batki
Journal:  Mil Med       Date:  2016-07       Impact factor: 1.437

4.  Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.

Authors:  Joseph P Schacht; Patrick K Randall; Patricia K Latham; Konstantin E Voronin; Sarah W Book; Hugh Myrick; Raymond F Anton
Journal:  Neuropsychopharmacology       Date:  2017-04-14       Impact factor: 7.853

5.  Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

Authors:  John C Umhau; Melanie L Schwandt; Julie Usala; Christopher Geyer; Erick Singley; David T George; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

6.  Mecamylamine treatment for alcohol dependence: a randomized controlled trial.

Authors:  Ismene L Petrakis; Elizabeth Ralevski; Ralitza Gueorguieva; Stephanie S O'Malley; Albert Arias; Kevin A Sevarino; Jane S Jane; Erin O'Brien; John H Krystal
Journal:  Addiction       Date:  2017-10-12       Impact factor: 6.526

7.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

8.  Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.

Authors:  Joseph P Schacht; Raymond F Anton; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

9.  Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice.

Authors:  Kelly Lei; Scott A Wegner; Ji-Hwan Yu; F Woodward Hopf
Journal:  Neuropharmacology       Date:  2016-08-11       Impact factor: 5.250

10.  [Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].

Authors:  M Hautzinger; H Wetzel; A Szegedi; A Scheurich; B Lörch; P Singer; D Schläfke; H Sittinger; T Wobrock; M J Müller; I Anghelescu
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.